ArticleScientific reports2026
Synergistic anticancer effects of peanut hairy root culture crude extract in combination with gemcitabine against cholangiocarcinoma.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cholangiocarcinoma (CCA) is a highly aggressive malignancy with limited treatment options and frequent chemoresistance. Peanut hairy root culture crude extract (PCE) has previously demonstrated selective cytotoxicity toward CCA cells. Here, we investigated the combinatorial effects of PCE with standard chemotherapeutic agents on CCA cell lines. In KKU-213 A cells, PCE exhibited antagonistic and additive interactions with gemcitabine (Gem) and 5-fluorouracil (5-FU), respectively. In contrast, both combinations showed synergistic effects in KKU-100 cells, with the strongest synergy observed for PCE and Gem. Further investigation in KKU-100 cells revealed that the PCE-Gem combination significantly induced apoptosis, as evidenced by increased levels of cleaved caspase-8, caspase-3, and PARP, without affecting cell cycle progression. Notably, no cytotoxic effect was observed in normal human fibroblasts (HSF-hTERT). In a nude mouse xenograft model, co-treatment with PCE and Gem significantly inhibited tumor growth and reduced Ki-67 expression compared to monotherapies. These findings suggest that PCE enhances the anticancer efficacy of Gem in CCA and may serve as a supportive combinatorial strategy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.